Distribution of global respiratory therapy market by condition 2021-2022
This statistic displays the global respiratory therapy market by condition based on the MAT (moving annual total) until the third quarter of 2022 (October 2021 to September 2022). In that year, the global asthma therapy market generated 24.8 billion U.S. dollars. Asthma is a major cause of morbidity and mortality globally and it is thought to have become more prevalent in the last decades. Fixed combination doses of preventative and symptomatic treatments are used to combat moderate to severe asthma.
